Clinical Trials Logo

Overweight clinical trials

View clinical trials related to Overweight.

Filter by:

NCT ID: NCT05104073 Completed - Clinical trials for Overweight and Obesity

Califormula Study: Calibrated Formula Feeding to Optimize Infant Growth

Start date: January 20, 2022
Phase: N/A
Study type: Interventional

The purpose of this voluntary research study is to determine if calibrated formula feeding recommendations can promote optimal growth for the first 6 months after birth for mothers with a pre-pregnancy body mass index of 25 or more.

NCT ID: NCT05096598 Completed - Healthy Volunteers Clinical Trials

A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial Participants

Start date: October 19, 2021
Phase: Phase 1
Study type: Interventional

The research study will investigate the safety and tolerability of ZP8396 in healthy study participants. In addition, the study will investigate how ZP8396 works in the body (pharmacokinetics and pharmacodynamics). Participants will receive 1 single dose either as an injection under the skin (subcutaneous, s.c.) or an injection into a vein of one arm (intravenous, i.v.). Participants will have 9 visits with the study team. One of these visits consists of 8 overnight stays at the study site. For each participant, the study will last up to 66 days.

NCT ID: NCT05092061 Completed - Clinical trials for Overweight and Obesity

Resistance Training in Adults With Obesity

Start date: October 14, 2021
Phase: N/A
Study type: Interventional

The purpose of this project is two-fold: (1) to assess if two different resistance training protocols elicit different responses in the acute phase and (2) to assess if the same two different protocols will elicit different long-term responses on muscular strength, body composition and cardiometabolic health. The project will include 30 adults with obesity (defined as BMI ≥ 30 or abdominal obesity according to the International Diabetes Federation). In the acute phase blood lactate, heart rate, enjoyment and perceived exertion will be assessed after the two resistance training protocols. In addition, the mean 24-h blood glucose concentration after exercise will be compared between the two protocols. For the long-term effects blood markers of cardiometabolic health, blood pressure, body composition, objectively measured physical activity and physical fitness will be assessed before and after the intervention. Also, perceived health-related quality of life will be assessed before and after the intervention.

NCT ID: NCT05090293 Completed - Clinical trials for Overweight and Obesity

Optimizing Weight Loss Outcomes Through Body Image Enhancement

Start date: September 13, 2021
Phase: N/A
Study type: Interventional

The study will examine if a standard group-delivered cognitive behavioral lifestyle intervention for weight loss can be improved via the incorporation of a novel body image intervention designed to address body image and improve weight loss outcomes in a sample of women with overweight/obesity.

NCT ID: NCT05077059 Completed - Clinical trials for Overweight and Obesity

Prevalence of Obesity and Overweight in Primary School Children in the Rhein-Neckar Region in Germany

Start date: October 1, 2021
Phase:
Study type: Observational

The study will determine the weight status in primary school children in the Rhein-Neckar Region in Germany and will analyse the development of height and weight in these children during the time of COVID-19 related restrictions by asking parents to provide data from childhood examinations. Additionally, interactions between cognitive abilities and weight-status will be studied.

NCT ID: NCT05061173 Completed - Hypertension Clinical Trials

Comparison of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults

Start date: September 10, 2021
Phase: N/A
Study type: Interventional

To compare the effects of aerobic, resistance and combined training in hypertensive obese patients

NCT ID: NCT05055362 Completed - Clinical trials for Overweight and Obesity

Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study

Start date: September 22, 2021
Phase: N/A
Study type: Interventional

The purpose of this research is to determine the effect a spiced-infused baked good has on inflammatory biomarkers in adults who are overweight and/or who has chronic kidney disease. Participants will be involved for 10 days in this research study.

NCT ID: NCT05054530 Completed - Clinical trials for Overweight and Obesity

Assessment of the Safety, Tolerability, and Pharmacokinetic of GMA106

Start date: November 11, 2021
Phase: Phase 1
Study type: Interventional

This will be a single centre, Phase 1, placebo-control, randomized, double-blind, sequential single and multiple ascending dose study to assess the safety, tolerability, and PK of GMA106 in healthy, overweight or obese subjects.

NCT ID: NCT05054153 Completed - Healthy Clinical Trials

Westlake Precision Nutrition Study

Start date: October 8, 2021
Phase: N/A
Study type: Interventional

This is a dietary intervention study, which aims to explore different diet challenges for glucose metabolism, including carbohydrates and intermittent fasting (IF) dietary pattern. Considering the glucose responses to the same food are largely heterogeneous among people, this study integrates the concepts of precision nutrition and N-of-1 design. The study also aims to explore differences in brain structure and function between participants with different Body Mass Index (BMI) from the perspective of gut-brain axis.

NCT ID: NCT05051579 Completed - Obesity Clinical Trials

A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities

Start date: September 29, 2021
Phase: Phase 2
Study type: Interventional

The main purpose of the study was to assess the effect of LY3502970 in participants who have obesity or are overweight.